Stalevo - carbidopa, levodopa, and entacapone
Navigation: NDC > Supplier starting with: N > NOVARTIS PHARMACEUTICALS CORPORATION| Field | Value |
|---|---|
| NDC Code: | 0078-0409 |
| Proprietary Name: | Stalevo |
| Suffix: | |
| Non-Proprietary Name: | carbidopa, levodopa, and entacapone |
| Dosage Form: | TABLET, FILM COATED |
| Method: | ORAL |
| Original Marketing Date: | 11-06-2003 |
| Category Name: | NDA |
| Application Number: | NDA021485 |
| Labeler: | NOVARTIS PHARMACEUTICALS CORPORATION |
| Substance Name: | CARBIDOPA; ENTACAPONE; LEVODOPA |
| Active Numerator Strength: | 37.5; 200; 150 |
| Active Ingredient Unit: | mg/1; mg/1; mg/1 |
| Pharm Classes: | Aromatic Amino Acid Decarboxylation Inhibitor [EPC],DOPA Decarboxylase Inhibitors [MoA],Aromatic Amino Acid Decarboxylation Inhibitor [EPC],DOPA Decarboxylase Inhibitors [MoA],Catechol O-Methyltransferase Inhibitors [MoA],Catechol-O-Methyltransferase Inhibitor [EPC] |
| DEA Schedule: |